BAJAJ BROKING

open-demat-imgOpen Demat
Login-imgLoginopens in a new tab
be-a-partner-imgBe a Partner
samadhan-imgSamadhanopens in a new tab
open-demat-imgOpen Demat
InstallInstall App
Download AppInstall App
Notification
Retaggio Industries IPO is Open!
Apply for the Retaggio Industries IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
Trade Nowopens in a new tab
framedot
img
jenburkt pharmaceuticals ltd. stock

Jenburkt Pharmaceuticals Ltd. Share Price

₹ 1035 14.54 (1.42%)
Apr 02 2025 12:35 PM Pharmaceuticals NSE: JENBURPH

Jenburkt Pharmaceuticals Ltd. Share Price Update

As of the latest trading session, Jenburkt Pharmaceuticals Ltd. share price is currently at 1035, which is up by 14.54 from its previous closing. Today, the stock has fluctuated between 1015.60 and 1035.90. Over the past year, Jenburkt Pharmaceuticals Ltd. has achieved a return of 43.61 %. In the last month alone, the return has been 3.19 %. Read More...

Jenburkt Pharmaceuticals Ltd. Performance

Day Range

Low1015.60 High1035.90
1035.90

52 Week Range

Low 702.15 High 1375.00
1035.90

Jenburkt Pharmaceuticals Ltd. Share Price

524731

JENBURPH

img img img img
Compare to down-arrow
View down-arrow
Display down-arrow
Studies down-arrow
No Data Available

Open Price

1020.45

Prev. Close

1020.45

Volume (Shares)

186.00

Total traded value

1.92

Upper Circuit

1224.50

Lower Circuit

816.40

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Jenburkt Pharmaceuticals Ltd. Fundamentals


(Standalone)

Market Cap (Cr) 457.20
PE Ratio (TTM) 14.34
Book Value / Share 357.46
Beta 1.00
ROE 19.44%
EPS (TTM) 71.16
Dividend Yield 1.50%
Net Profit Qtr (Cr) 6.51

Jenburkt Pharmaceuticals Ltd. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 36.89
Operating Expense 28.96
Net Profit 6.51
Net Profit Margin (%) 17.64
Earnings Per Share (EPS) 14.75
EBITDA 10.39
Effective Tax Rate (%) 31.65
Particulars SEP 2024 (Values in Cr)
Revenue 41.22
Operating Expense 30.55
Net Profit 9.60
Net Profit Margin (%) 23.28
Earnings Per Share (EPS) 21.75
EBITDA 13.28
Effective Tax Rate (%) 23.32
Particulars JUN 2024 (Values in Cr)
Revenue 32.54
Operating Expense 23.88
Net Profit 7.42
Net Profit Margin (%) 22.80
Earnings Per Share (EPS) 16.80
EBITDA 10.69
Effective Tax Rate (%) 26.34
Particulars MAR 2024 (Values in Cr)
Revenue 38.84
Operating Expense 29.66
Net Profit 7.88
Net Profit Margin (%) 20.28
Earnings Per Share (EPS) 17.86
EBITDA 11.04
Effective Tax Rate (%) 23.91
Particulars DEC 2023 (Values in Cr)
Revenue 35.66
Operating Expense 29.16
Net Profit 5.40
Net Profit Margin (%) 15.14
Earnings Per Share (EPS) 12.25
EBITDA 8.54
Effective Tax Rate (%) 31.12
Particulars MAR 2024 (Values in Cr)
Revenue 141.97
Operating Expense 111.46
Net Profit 25.98
Net Profit Margin (%) 18.29
Earnings Per Share (EPS) 58.86
EBITDA 37.79
Effective Tax Rate (%) 26.15
Particulars MAR 2023 (Values in Cr)
Revenue 136.75
Operating Expense 109.01
Net Profit 24.61
Net Profit Margin (%) 17.99
Earnings Per Share (EPS) 53.90
EBITDA 35.48
Effective Tax Rate (%) 25.13
Particulars MAR 2022 (Values in Cr)
Revenue 123.98
Operating Expense 99.05
Net Profit 22.30
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 48.58
EBITDA 32.20
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 109.29
Operating Expense 91.96
Net Profit 16.50
Net Profit Margin (%) 15.09
Earnings Per Share (EPS) 35.96
EBITDA 24.15
Effective Tax Rate (%) 23.75
Particulars MAR 2020 (Values in Cr)
Revenue 118.89
Operating Expense 101.98
Net Profit 14.87
Net Profit Margin (%) 12.50
Earnings Per Share (EPS) 32.40
EBITDA 23.97
Effective Tax Rate (%) 29.65
Particulars MAR 2024 (Values in Cr)
Book Value / Share 328.42
ROE % 19.44
ROCE % 25.67
Total Debt to Total Equity 0.01
EBITDA Margin 26.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 277.32
ROE % 20.53
ROCE % 26.04
Total Debt to Total Equity 0.04
EBITDA Margin 25.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 255.77
ROE % 20.66
ROCE % 25.94
Total Debt to Total Equity 0.05
EBITDA Margin 25.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 214.55
ROE % 18.49
ROCE % 22.77
Total Debt to Total Equity 0.05
EBITDA Margin 22.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 174.32
ROE % 18.89
ROCE % 24.71
Total Debt to Total Equity 0.07
EBITDA Margin 20.16
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 79.19
Total Assets 165.09
Total Liabilities 165.09
Total Equity 144.94
Share Outstanding 4413300
Price to Book Ratio 2.10
Return on Assets (%) 15.73
Return on Capital (%) 17.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 53.80
Total Assets 141.81
Total Liabilities 141.81
Total Equity 122.38
Share Outstanding 4413300
Price to Book Ratio 2.40
Return on Assets (%) 17.35
Return on Capital (%) 19.71
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 49.02
Total Assets 142.94
Total Liabilities 142.94
Total Equity 117.38
Share Outstanding 4589378
Price to Book Ratio 2.22
Return on Assets (%) 15.59
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.50
Total Assets 121.18
Total Liabilities 121.18
Total Equity 98.46
Share Outstanding 4589378
Price to Book Ratio 1.86
Return on Assets (%) 13.61
Return on Capital (%) 16.15
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 57.69
Total Assets 104.30
Total Liabilities 104.30
Total Equity 80.00
Share Outstanding 4589378
Price to Book Ratio 1.82
Return on Assets (%) 14.25
Return on Capital (%) 17.82
Particulars MAR 2024 (Values in Cr)
Net Income 25.97
Cash from Operations 16.38
Cash from Investing -0.58
Cash from Financing -7.07
Net change in Cash 0.46
Free Cash Flow 18.94
Particulars MAR 2023 (Values in Cr)
Net Income 24.60
Cash from Operations 25.27
Cash from Investing 2.61
Cash from Financing -21.04
Net change in Cash -1.37
Free Cash Flow 27.38
Particulars MAR 2022 (Values in Cr)
Net Income 22.29
Cash from Operations 16.83
Cash from Investing -1.20
Cash from Financing -5.53
Net change in Cash 2.53
Free Cash Flow 19.88
Particulars MAR 2021 (Values in Cr)
Net Income 16.50
Cash from Operations 25.29
Cash from Investing -18.78
Cash from Financing -0.71
Net change in Cash -0.04
Free Cash Flow 26.43
Particulars MAR 2020 (Values in Cr)
Net Income 14.86
Cash from Operations 20.48
Cash from Investing -2.87
Cash from Financing -10.83
Net change in Cash 1.30
Free Cash Flow 25.03

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1013.00
  • 26 Days 1009.10
  • 10 Days 1004.30
  • 50 Days 1044.20
  • 12 Days 1002.20
  • 100 Days 1073.70
  • 20 Days 1002.70
  • 200 Days 1040.20

Jenburkt Pharmaceuticals Ltd. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Jenburkt Pharmaceuticals Ltd. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Stock Holding

View Live Stock Screeners

arrow-right

Holding

Public
53.19
Promoter Holdings
46.68
FII
0.0
DII
0.11
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Bhuta Holdings Private Limited Shareholding of Promoter and Promoter Group 616128.0 13.96
Jayshree Uttam Bhuta Shareholding of Promoter and Promoter Group 536480.0 12.16
Kalindi Hemendra Bhuta Shareholding of Promoter and Promoter Group 399700.0 9.06
Ashish Uttam Bhuta Shareholding of Promoter and Promoter Group 261127.0 5.92
Nirmala Vinodkumar Daga Public Shareholding 145493.0 3.3
Mahesh Harshad Bhuta Shareholding of Promoter and Promoter Group 67860.0 1.54
Ranjeet Singh Sibia Public Shareholding 65650.0 1.49
Bhavika Ashish Bhuta Shareholding of Promoter and Promoter Group 51637.0 1.17
Kunti Ketan Gala Shareholding of Promoter and Promoter Group 51278.0 1.16
Optirational Ventures Llp Public Shareholding 50973.0 1.15
Rajiv Garg Public Shareholding 47750.0 1.08
Parshva Kumar Daga Public Shareholding 46557.0 1.05
Sushila Paraskumar Daga Public Shareholding 46346.0 1.05
Varun Daga Public Shareholding 45450.0 1.03
Bharath C Jain Public Shareholding 45000.0 1.02
Kaushik Daga Public Shareholding 45000.0 1.02
Riddhi Haresh Shroff Shareholding of Promoter and Promoter Group 32240.0 0.73
Jagruti Ketan Bhuta Shareholding of Promoter and Promoter Group 27000.0 0.61
Shivani Haresh Shroff Shareholding of Promoter and Promoter Group 17000.0 0.39
Prakash H Bhuta Shareholding of Promoter and Promoter Group 0.0 0.0

Jenburkt Pharmaceuticals Ltd.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-19 14.4 Final 2023-07-20 Equity shares 2022-07-21 12.0 Final 2022-07-23 Equity shares 2021-08-30 10.2 Final 2021-09-01 Equity shares 2020-03-18 8.1 Interim 2020-03-19 Equity shares 2019-07-22 10.2 Final 2019-07-24 Equity shares 2018-07-23 6.0 Final 2018-07-25 Equity shares 2018-03-27 3.0 Interim 2018-03-28 Equity shares 2017-07-21 8.1 Final 2017-07-25 Equity shares 2016-07-19 0.9 Final 2016-07-21 Equity shares 2016-03-17 6.3 Interim 2016-03-18 Equity shares 2015-08-31 6.3 Final 2015-09-02 Equity shares 2014-09-03 5.1 Final 2014-09-05 Equity shares 2013-09-18 4.2 Final 2013-09-20 Equity shares 2012-07-23 3.5 Final 2012-07-25 Equity shares 2011-07-21 3.5 Final 2011-07-23 Equity shares 2010-07-21 3.0 Final 2010-07-23 Equity shares 2009-07-23 1.8 Final 2009-07-25 Equity shares 2008-07-23 1.25 Final 2008-07-25 Equity shares 2007-07-18 1.25 Final 2007-07-20 Equity shares 2005-08-10 0.0 Final 2005-08-12 Equity shares

Learn More About Stocks

About Jenburkt Pharmaceuticals Ltd.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Jenburkt Pharmaceuticals Ltd.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

Invest
investment-card-icon

IPOs

Your gateway to future financial opportunities

Invest
investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

Invest
investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest
investment-card-icon

Frequently Asked Questions

What is the Share Price of Jenburkt Pharmaceuticals Ltd?

Answer Field

The share price of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1035.90.

What is the Market Cap of Jenburkt Pharmaceuticals Ltd?

Answer Field

The market cap of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 4,57.20 Cr. as of now.

What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1375.00 and ₹ 701.20.

How to Buy Jenburkt Pharmaceuticals Ltd share?

Answer Field

You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Jenburkt Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 43.61%.

What is the Current Share Price of Jenburkt Pharmaceuticals Ltd?

Answer Field

Jenburkt Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1035.90 as on Apr 02 2025 12:35 PM.

What is the Market Cap of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

The market cap of Jenburkt Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 4,57.20 as on Apr 02 2025 12:35 PM.

What is the P/E Ratio of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

As on Apr 02 2025 12:35 PM the price-to-earnings (PE) ratio for Jenburkt Pharmaceuticals Ltd share is 14.34.

What is the PB ratio of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

As on Apr 02 2025 12:35 PM, the price-to-book (PB) ratio for Jenburkt Pharmaceuticals Ltd share is 357.46.

How to Buy Jenburkt Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Jenburkt Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jenburkt Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download
9 lakh+ Users
icon-with-text
4.3+ App Rating
icon-with-text
4 Languages
icon-with-text
₹4300+ Cr MTF Book
icon-with-text
Open Demat Account

TRENDING CALCULATORS AND STOCKS ON BAJAJ BROKING

Popular Stock

top-popular-on-bfsl

POPULAR STOCKS: Tata Motors Share Price Infosys Share Price IRFC Share Price SBI Card Share Price Cipla Share Price NBCC Share Price IDFC First Bank Share Price IRCTC Share Price PNB Share Price Zomato Share Price Vodafone Idea Share Price Axis Bank Share Price JSW Steel Share Price Bandhan Bank Share Price SBI Share Price Tata Steel Share Price ONGC Share Price Ashok Leyland Share Price Paytm Share Price Subex Share Price DLF Share Price Reliance Share Price HDFC Bank Share Price Suzlon Share Price IOC Share Price HUL Share Price Asian Paints Share Price Bank Of Baroda Share Price ITC Share Price TCS Share Price HFCL Share Price Icici Bank Share Price Tata Chemicals Share Price CDSI Share Price MRF Share Price Tata Power Share Price Adani Green share price BPCL Share Price Vedanta Share Price Dmart Share Price Hindalco Share Price LIC Share Price SAIL Share Price Adani Port Share Price IEX Share Price Nalco Share Price L&T Share Price Adani Power Share Price BHEL Share Price Bajaj Finance Share Price Canara Bank Share Price Indusind Bank Share Price Gail Share Price Yes Bank Share Price Wipro Share Price Happiest Minds Share Price Coal India Share Price Maruti Share Price Reliance Power Share Price

 

INDIAN INDICES: Nifty 50 Share Price SENSEX Share Price Nifty Next 50 Share Price BSE100 Share Price Nifty Bank Share Price LRGCAP Share Price Nifty 100 Share Price MIDCAP Share Price Nifty 200 Share Price SMLCAP Share Price Nifty 500 Share Price BSE500 Share Price Nifty Midcap 50 Share Price ALLCAP Share Price NIFTY SMLCAP 50 Share Price BSE200 Share Price India VIX Share Price BSEIPO Share Price

ATTENTION INVESTORS:

“Investments in securities market are subject to market risk, read all the scheme related documents carefully before investing."

"Prevent Unauthorized transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/ Demat Account directly from Exchange/CDSL/NSDL at the end of the day. Issued in the interest of investors."

" We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services."  

"KYC...

loader